Sagefield Capital’s SomaLogic SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-19,088
Closed -$48.3K – 111
2023
Q4
$48.3K Buy
+19,088
New +$44.5K 0.01% 85

Sagefield Capital's SLGC Position: Q1 2024 in Review

Sagefield Capital sold out of SomaLogic (SLGC) in Q1 2024, closing a stake of 19,088 shares — an estimated $48.3K sold.

Sagefield Capital first reported a position in SLGC in Q4 2023 and held it in 1 quarter. The position peaked at $48.3K in Q4 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Sagefield Capital reported no remaining SomaLogic position as of Q1 2024 after selling out during the quarter.
  • Sagefield Capital sold 19,088 SomaLogic shares in Q1 2024, an estimated $48.3K.
  • Sagefield Capital first reported a position in SomaLogic in Q4 2023 and held it in 1 quarter.
  • Sagefield Capital's SomaLogic position peaked at $48.3K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held SomaLogic as of Q1 2024.

Based on Sagefield Capital's 13F filing for Q1 2024, filed 15 May 2024.